Comparison 33. Oral immunosuppressants: oral cyclosporin versus alitretinoin.

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
1 Primary: investigator‐rated good/excellent control (IGA) after 24 weeks	1		Risk Ratio (M‐H, Random, 95% CI)	Totals not selected
2 Primary: participant‐rated good/excellent control (PGA) after 24 weeks	1		Risk Ratio (M‐H, Random, 95% CI)	Totals not selected
3 Primary: adverse events	1		Risk Ratio (M‐H, Random, 95% CI)	Totals not selected